Aster Angagaw's most recent trade in Lucid Diagnostics Inc was a trade of 59,000 Employee stock option (right to buy) done . Disclosure was reported to the exchange on Feb. 18, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lucid Diagnostics Inc | Aster Angagaw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 59,000 | 59,000 | - | - | Employee stock option (right to buy) | |
| Owens & Minor, Inc. | Aster Angagaw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2021 | 4,098 | 4,708 (0%) | 0% | 0 | Common Stock | |
| Owens & Minor, Inc. | Aster Angagaw | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2021 | 610 | 610 (0%) | 0% | 0 | Common Stock |